Casdin Capital Overview
- Investor Type
- Hedge Fund
- Status
- Active
- Professionals
- 6
- Investments
- 155
- Portfolio
- 77
- Exits
- 48
Casdin Capital General Information
Description
Founded in 2012, Casdin Capital is a sector-oriented hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.
Contact Information
Website
www.casdincapital.com
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
- 1350 Avenue of the Americas
- Suite 2405
- New York, NY 10019
- United States
+1 (212) 000-0000
Casdin Capital Investments (155)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Science 37 | 07-May-2021 | PIPE | 00000 | Enterprise Systems (Healthcare) | Generating Revenue | |
| 0000 000000000000 | 06-May-2021 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Startup | |
| 00000000000 000000 | 04-May-2021 | 0000 | 00000 | Laboratory Services (Healthcare) | Profitable | |
| 0000000 0000000000 | 30-Apr-2021 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | |
| 0000000000 | 27-Apr-2021 | 00000 00000 | 00000 | Drug Discovery | Profitable | |
| 00000000 0000 | 20-Apr-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000000 0000000 |
| 000 00000000 | 14-Apr-2021 | 00000 00000 | 00000 | Decision/Risk Analysis | Generating Revenue | 000 000000 |
| 00000 000000000000 | 14-Apr-2021 | 0000 | 00000 | Drug Discovery | Pre-Clinical Trials | |
| Treeline Biosciences | 12-Apr-2021 | Early Stage VC | 00000 | Biotechnology | Stealth | |
| Ventus Therapeutics | 08-Apr-2021 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue | 000 000000 |
Casdin Capital Exits (48)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Recursion | 16-Apr-2021 | IPO | 00000 |
| 00 0000 00000000 0 | 23-Feb-2021 | 000 | 00000 |
| 0000000 0000000000 | 12-Feb-2021 | 000 | 00000 |
| 000000 000000 | 07-Jan-2021 | 0000000 000000 | 00000 |
| 000000 0000000 000 | 05-Jan-2021 | 000000000000000000 | 00.00 |
| 000 0000000 | 18-Dec-2020 | 000 | 00000 |
| 0000 | 11-Dec-2020 | 000 | 00000 |
| 0000000 0000000000 | 23-Oct-2020 | 000 | 00000 |
| Codiak | 14-Oct-2020 | IPO | 000.00 |
| Kronos Bio | 09-Oct-2020 | IPO | 00000 |
Casdin Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCasdin Capital Team (20)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Evans Apeadu | Chief Financial Officer | New York, NY | |||
| Lawrence Canzoneri | Chief Financial Officer | New York, NY | |||
| Alexandria Fisk | Chief Operating Officer | New York, NY | |||
| Eli Casdin | Founder & Chief Investment Officer | 00 | 0 | 00 | New York, NY |
| Kelly Galvin | Director, IR & Business Development | New York, NY |
Casdin Capital Co-Investors (385)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GV | 22 | 0 |
|
|
|
| Alexandria Venture Investments | 00 | 0 |
|
|
|
| Fidelity Management & Research | 00 | 0 | 0 |
|
|
| Perceptive Advisors | 00 | 0 | 0 |
|
|
| Third Rock Ventures | 00 | 0 | 0 |
|
|